Description
A COX-2 inhibitor; 10-fold selective for COX-2 over COX-1; reduces LPS-induced PGE2 production in bovine arterial endothelial cells (IC50 = 1 μM); reduces vascular permeability, edema, and nociception in a rat model of adjuvant-induced arthritis from 25-100 mg/kg
Formal name: 4-(3-methyl-2-buten-1-yl)-1,2-diphenyl-3,5-pyrazolidinedione
Synonyms:
Molecular weight: 320.4
CAS: 30748-29-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Cyclooxygenases||Research Area|Immunology & Inflammation|Autoimmunity|Rheumatoid Arthritis||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway